Effects of adjuvant trastuzumab with chemotherapy (ATWC) in T1N0 HER2 positive (HER2+) breast cancer.
2015
e11595 Background: Adjuvant trastuzumab with chemotherapy (ATWC) reduces recurrence and death in prospective trials of HER2+ breast cancer (BC). T1N0 ( ≤ 2cm node-negative) patients were however mo...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI